Lindome, Sweden

Tomas B Alminger


Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 1991-1993

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Tomas B Alminger

Introduction

Tomas B Alminger is a notable inventor based in Lindome, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in developing novel compounds for treating gastric acid-related diseases. His work has led to the filing of multiple patents, showcasing his innovative approach to medicine.

Latest Patents

Alminger holds 2 patents that focus on unique pharmaceutical compositions. His latest patents include "Certain pyridyl[(methylthio- or methyl sulfinyl)-2" which details novel compounds designed to treat conditions such as gastritis, gastric ulcers, duodenal ulcers, and reflux esophagitis. Another patent, titled "Novel pharmacological compounds," emphasizes compounds with gastric and inhibiting effects, further highlighting his commitment to advancing medical treatments.

Career Highlights

Throughout his career, Alminger has been associated with Aktiebolaget Hassle, where he has played a crucial role in research and development. His expertise in pharmacology has positioned him as a key figure in the pharmaceutical industry, contributing to the advancement of therapeutic solutions.

Collaborations

Alminger has collaborated with esteemed colleagues, including Per L Lindberg and Gunnel E Sunden. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pursuit of medical advancements.

Conclusion

Tomas B Alminger's contributions to the field of pharmaceuticals through his patents and collaborations demonstrate his dedication to improving healthcare. His innovative work continues to impact the treatment of gastric acid-related diseases, making him a significant figure in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…